9730 Federal Register / Vol. 80, No. 36 / Tuesday, February 24, 2015 / Notices 

• The nominee’s contact information 

and current occupation or position; 

• The nominee’s resume or 

curriculum vitae, including prior or 

current membership on other National 

Institute for Occupational Safety and 

Health (NIOSH), CDC, or HHS advisory 

committees or other relevant 

organizations, associations, and 

committees; 

• The category of membership 

(epidemiologist, environmental 

medicine or environmental health 

specialist, occupational physician with 

experience treating WTC rescue and 

recovery workers, occupational 

physician, representative of WTC 

responders, or toxicologist) that the 

candidate is qualified to represent; 

• A summary of the background, 

experience, and qualifications that 

demonstrates the nominee’s suitability 

for the nominated membership category; 

• Articles or other documents the 

nominee has authored that indicate the 

nominee’s knowledge and experience in 

relevant subject categories; and 

• A statement that the nominee is 

aware of the nomination, is willing to 

regularly attend and participate in 

STAC meetings, and has no known 

conflicts of interest that would preclude 

membership on the Committee. 

STAC members will be selected upon 

the basis of their relevant experience 

and competence in their respective 

categorical fields. The information 

received through this nomination 

process, in addition to other relevant 

sources of information, will assist the 

WTC Program Administrator in 

appointing members to serve on the 

STAC. In selecting members, the WTC 

Program Administrator will consider 

individuals nominated in response to 

this Federal Register notice as well as 

other qualified individuals. 

The CDC is committed to bringing 

greater diversity of thought, perspective, 

and experience to its advisory 

committees. Nominees from all races, 

genders, ages, and persons living with 

disabilities are encouraged to apply. 

Nominees must be U.S. citizens. 

Candidates invited to serve will be 

asked to submit the ‘‘Confidential 

Financial Disclosure Report,’’ OGE 

Form 450. This form is used by CDC to 

determine whether there is a financial 

conflict between that person’s private 

interests and activities and their public 

responsibilities as a Special Government 

Employee as well as any appearance of 

a loss of impartiality, as defined by 

Federal regulation. The form may be 

viewed and downloaded at http://

www.oge.gov/Forms-Library/OGE-Form450-Confidential-Financial-DisclosureReport/. This form should not be 

submitted as part of a nomination. 

DATES: Nominations must be submitted 

(postmarked or electronically received) 

by March 31, 2015. 

Submissions must be electronic or by 

mail. Submissions should reference 

docket 229–C. Electronic submissions: 

You may electronically submit 

nominations, including attachments, to 

nioshdocket@cdc.gov. Attachments in 

Microsoft Word are preferred. Regular, 

Express, or Overnight Mail: Written 

nominations may be submitted (one 

original and two copies) to the following 

address only: NIOSH Docket 229–C, 

c/o Mia Wallace, Committee 

Management Specialist, National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention, 1600 Clifton Rd. NE., MS: 

E–20, Atlanta, Georgia 30333. 

Telephone and facsimile submissions 

cannot be accepted. For further 

information contact: Paul Middendorf, 

Senior Health Scientist, 1600 Clifton Rd. 

NE., MS: E–20, Atlanta, GA 30333; 

telephone (404) 498–2500 (this is not a 

toll-free number); email pmiddendorf@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–03682 Filed 2–23–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10407] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by March 26, 2015. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–5806 OR Email: 

OIRA_submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/Paperwork

ReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 36 / Tuesday, February 24, 2015 / Notices 9731 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Summary of 

Benefits and Coverage and Uniform 

Glossary; Use: Section 2715 of the PHS 

Act directs the Department of Health 

and Human Services (HHS), the 

Department of Labor (DOL), and the 

Department of the Treasury 

(collectively, the Departments), in 

consultation with the National 

Association of Insurance Commissioners 

(NAIC) and a working group comprised 

of stakeholders, to ‘‘develop standards 

for use by a group health plan and a 

health insurance issuer in compiling 

and providing to applicants, enrollees, 

and policyholders and certificate 

holders a summary of benefits and 

coverage explanation that accurately 

describes the benefits and coverage 

under the applicable plan or coverage.’’ 

To implement these disclosure 

requirements, collection of information 

requests relate to the provision of the 

following: Summary of benefits and 

coverage, which includes coverage 

examples; a uniform glossary of health 

coverage and medical terms; and a 

notice of modifications. Form Number: 

CMS–10407 (OMB control number 

0938–1146); Frequency: Annual; 

Affected Public: Private Sector— 

Business or other for-profits and Notfor-profit institutions; Number of 

Respondents: 126,500; Number of 

Responses: 41,153,858; Total Annual 

Hours: 322,411. (For policy questions 

regarding this collection, contact 

Heather Raeburn at 301–492–4224.) 

Dated: February 18, 2015. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2015–03650 Filed 2–23–15; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[OMB No.: 0970–0139] 

Uniform Project Description (UPD) 

Project Narrative Format for 

Discretionary Grant Application 

Forms; Correction 

AGENCY: Administration for Children 

and Families, HHS. 

ACTION: Notice; correction. 

SUMMARY: The Administration for 

Children and Families published a 

document in the Federal Register of 

February 17, 2015, concerning a request 

for comments on a proposed 

information collection. The document 

contained an incorrect citation. 

FOR FURTHER INFORMATION CONTACT: 

Christopher Beach, Senior Grants Policy 

Specialist, Division of Grants Policy, 

Office of Administration, 

Administration for Children and 

Families, telephone (202) 401–1539. 

Correction: In the Federal Register of 

February 17, 2015, in FR. Doc. 2015– 

03144, on page 8324, in the third 

column, correct the last sentence of the 

‘‘Description’’ caption to read: 

‘‘Guidance for the content of 

information requested in the Uniform 

Project Description is based in 45 CFR 

75.203 and Appendix I to 45 CFR part 

75.’’ 

Christopher Beach, 

Senior Grants Policy Specialist, Office of 

Administration. 

[FR Doc. 2015–03627 Filed 2–23–15; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2015–D–0235] 

Evaluating the Effectiveness of New 

Animal Drugs for the Reduction of 

Pathogenic Shiga Toxin-Producing 

Escherichia coli in Cattle; Draft 

Guidance for Industry; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of a draft guidance for 

industry (GFI #229) entitled ‘‘Evaluating 

the Effectiveness of New Animal Drugs 

for the Reduction of Pathogenic Shiga 

Toxin-Producing E. coli in Cattle.’’ The 

purpose of this document is to provide 

recommendations to industry relating to 

study design and describe criteria the 

Center for Veterinary Medicine (CVM) 

thinks are the most appropriate for the 

evaluation of the effectiveness of new 

animal drugs that are intended to reduce 

pathogenic Shiga toxin-producing E. 

coli (STEC) in cattle. 

DATES: Although you can comment on 

any guidance at any time (see 21 CFR 

10.115(g)(5)), to ensure that the Agency 

considers your comment on this draft 

guidance before it begins work on the 

final version of the guidance, submit 

either electronic or written comments 

on the draft guidance by April 27, 2015. 

ADDRESSES: Submit written requests for 

single copies of the guidance to the 

Communications Staff (HFV–12), Center 

for Veterinary Medicine, Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855. Send one selfaddressed adhesive label to assist that 

office in processing your requests. See 

the SUPPLEMENTARY INFORMATION section 

for electronic access to the draft 

guidance document. 

Submit electronic comments on the 

draft guidance to http://

www.regulations.gov. Submit written 

comments to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. 

FOR FURTHER INFORMATION CONTACT: 

Joshua R. Hayes, Center for Veterinary 

Medicine (HFV–133), Food and Drug 

Administration, 7500 Standish Pl., 

Rockville, MD 20855, 240–402–0651, 

Joshua.hayes@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

FDA is announcing the availability of 

a draft guidance for industry (GFI #229) 

entitled ‘‘Evaluating the Effectiveness of 

New Animal Drugs for the Reduction of 

Pathogenic Shiga Toxin-Producing E. 

coli in Cattle.’’ This draft guidance 

provides recommendations to industry 

relating to study design and describes 

criteria CVM thinks are the most 

appropriate for the evaluation of the 

effectiveness of new animal drugs that 

are intended to reduce pathogenic STEC 

in cattle. It discusses general 

considerations regarding the 

development of protocols, study 

conduct, animal welfare, substantial 

evidence of effectiveness, experimental 

parameters, nutritional content of 

experimental diets, and the assessment 

of drug concentrations in experimental 

diets. It also discusses the studies and 

analyses CVM recommends for sponsors 


tkelley on DSK3SPTVN1PROD with NOTICES